Silencing NOB1 enhances doxorubicin antitumor activity of the papillary thyroid carcinoma in vitro and in vivo

E-ISSN： 1791-2431|33|3|1551-1559

ISSN： 1021-335X

Source： Oncology Reports, Vol.33, Iss.3, 2015-01, pp. : 1551-1559

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Adenovirus-mediated siRNA targeting NOB1 inhibits tumor growth and enhances radiosensitivity of human papillary thyroid carcinoma in vitro and in vivo

Oncology Reports, Vol. 32, Iss. 6, 2014-01 ,pp. : 2411-2420

Spandidos Publications

Access to resources Recommend Favorite

COX-2 silencing enhances tamoxifen antitumor activity in breast cancer in vivo and in vitro

By Du Ye Shi Aiping Han Bing Li Sijie Wu Di Jia Hongyao Zheng Chao Ren Liqun Fan Zhimin

International Journal of Oncology, Vol. 44, Iss. 4, 2014-04 ,pp. : 1385-1393

Spandidos Publications

Access to resources Recommend Favorite

Knockout of ADAM10 enhances sorafenib antitumor activity of hepatocellular carcinoma in vitro and in vivo

Oncology Reports, Vol. 32, Iss. 5, 2014-01 ,pp. : 1913-1922

Spandidos Publications

Access to resources Recommend Favorite

NRP1 silencing suppresses hepatocellular carcinoma cell growth in vitro and in vivo

Experimental and Therapeutic Medicine, Vol. 5, Iss. 1, 2013-01 ,pp. : 150-154

Spandidos Publications

Access to resources Recommend Favorite

Aspirin enhances doxorubicin-induced apoptosis and reduces tumor growth in human hepatocellular carcinoma cells in vitro and in vivo

International Journal of Oncology, Vol. 40, Iss. 5, 2012-01 ,pp. : 1636-1642

Spandidos Publications

Access to resources Recommend Favorite